After 72 h, SAM and decitabine/SAM-treated groups showed a slightly significant reduction in migration (89/91% of controls) and invasion potential (87/90% of controls) ( Figure 1 B,C).
← all excerpts
The Simultaneous Treatment of PC-3 Cells with the DNA-Demethylating Agent Decitabine and S-Adenosylmethionine Leads to Synergistic Anticancer Effects.
1
—
—